You are here

  • Home
  • Archive
  • Volume 10, Issue 6
  • Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study

Article info

Article menu

Download PDFPDF

XML
Pharmacology and therapeutics
Original research
Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study

Authors

  • Thomas J Moore Institute for Safe Medication Practices, Alexandria, Virginia, USADepartment of Epidemiology, The George Washington University Milken Institute School of Public Health, Washington, DC, USA PubMed articlesGoogle scholar articles
  • James Heyward Center for Drug Safety and Effectiveness, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Gerard Anderson Department of Heath Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • G Caleb Alexander Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USADivision of General Internal Medicine, Johns Hopkins Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Thomas J Moore; tmoore{at}ismp.org
View Full Text

Citation

Moore TJ, Heyward J, Anderson G, et al
Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study
BMJ Open 2020;10:e038863. doi: 10.1136/bmjopen-2020-038863

Publication history

  • Received March 26, 2020
  • Revised May 8, 2020
  • Accepted May 11, 2020
  • First published June 11, 2020.
Online issue publication 
April 12, 2022
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.